Monday, October 17, 2022 from 9:00 AM to 10:30 AM PDT at Imperial Ballroom B
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-22-170-L04-P
Activity Type: An Application-Based Activity
This 90-minute revised session will have 3 speakers who will present on the following topics. The first presentation will serve as a foundational presentation. It will provide an overview of the different types of public health emergencies, framework for responses, and the roles of government and nongovernment agencies and stakeholders. The second presentation will build upon and complement the first session via a continued focus on emergency management, but also narrowing to the role of the pharmacist in responding to natural and manmade natural disasters. Ideally, it will include an opportunity to engage with a presenter who has participated in large scale response efforts. The third presentation will serve as the transition to discussion of the COVID-19 pandemic. This session will focus on the practice challenges created by COVID-19 and subsequent innovations to ensure patient access to care. However, to align with the timeline of the meeting, presenters will also address outcomes from those challenge and information on changes that persisted past the acute emergency.
| Moderator: Adriane N. Irwin, Pharm.D., MS, FCCP, BCACP
Associate Professor (Clinical), Oregon State University (OSU) College of Pharmacy and Chair, Department of Pharmacy Practice View Biography |
Learning Objectives
1. Correlate various types of public health emergencies and their effects on human health.
2. Articulate the core capabilities of national preparedness.
3. Contrast the roles of federal, state, and local agencies in emergency preparedness and response, including responsibilities in sustained response efforts.
4. Discuss how pharmacists can contribute to and support public health emergencies.
5. Describe how the drug supply and medication use process is altered during natural and manmade disasters.
6. Construct strategies for how pharmacists can volunteer to participate in emergency response efforts by federal agencies and similar agencies.
7. Describe strategies employed for addressing the immediate needs created by the COVID-19 pandemic.
8. Evaluate the impact of pharmacy practice changes in response to COVID-19 with a focus on long-lasting changes.
9. Identify strategies for preparedness for future pandemics and other natural or manmade disasters requiring emergency response.